Experienced in Epidermodysplasia Verruciformis

Keiichi Yamanaka

Tsu, JP 
Experienced in Epidermodysplasia Verruciformis
Tsu, JP 
OverviewLocationsClinical Research

Overview

Keiichi Yamanaka practices in Tsu, Japan. Yamanaka is rated as an Experienced expert by MediFind in the treatment of Epidermodysplasia Verruciformis. Their top areas of expertise are Rickettsialpox, Pyoderma Gangrenosum, Spotted Fever, Kidney Transplant, and Splenectomy.

Their clinical research consists of co-authoring 131 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Epidermodysplasia Verruciformis.

Locations

Tsu, Japan
Other Locations
Miemachi, Japan
Nara-shi, Japan
Kashihara-shi, Japan
Osaka, Japan
Nishinomiya-hama, Japan
Suita, Japan
Kyoto, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
A Multicenter, Long-Term Extension to Evaluate the Long-term Safety and Maintenance of Treatment Effect of LY3074828 in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-3
Enrollment Status: Terminated
Publish Date: March 21, 2023
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Comparing the Efficacy and Safety of Mirikizumab to Secukinumab and Placebo in Patients With Moderate-to-Severe Plaque Psoriasis OASIS-2
Enrollment Status: Completed
Publish Date: March 30, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

131 Total Publications

A case of Stewart-Treves syndrome during the treatment with immune checkpoint inhibitor for occult malignant melanoma.
A case of Stewart-Treves syndrome during the treatment with immune checkpoint inhibitor for occult malignant melanoma.
Journal: JAAD case reports
Published: October 13, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Yamanaka's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 64 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile